Ainsley K. Burke

Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis Cvon Wagner M, Huber M, Berg T, et al (Universitätsklinikum des Saarlandes, Hombrug/Saar, Germany; Johann Wolfgang Goethe-Universität, Frankfurt, Germany; Campus Virchow-Klinikum, Berlin; et al) Gastroenterology 129:522–527, 2005§

International, Multicenter, Randomized, Controlled Study Comparing Dynamically Individualized Versus Standard Treatment in Patients With Chronic Hepatitis CZeuzem S, for the DITTO-HCV Study Group (Saarland Univ, Homburg/Saar, Germany; et al) J Hepatol 43:256–257, 2005§

A Meta-analysis of Transjugular Intrahepatic Portosystemic Shunt Versus Paracentesis for Refractory AscitesAlbillos A, Bañares R, González M, et al (Universidad de Alcalá, Madrid; Universidad Complutense, Madrid; Alce Ingeniería, Madrid) J Hepatol 43:990–996, 2005§

Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients With Recurrent Chronic Hepatitis CBizollon T, Pradat P, Mabrut J-Y, et al (Hôtel-Dieu, Lyon, France; Hopital de la Croix-Rousse, Lyon, France; Laboratoire Marcel Merieux, Lyon, France) Am J Transplant 5:1909–1913, 2005§

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients With Nonalcoholic Steatohepatitis: A Pilot StudyHuang MA, Greenson JK, Chao C, et al (Univ of Michigan, Ann Arbor) Am J Gastroenterol 100:1072–1081, 2005§

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort StudyAdams LA, Lymp JF, St Sauver J, et al (Mayo Clinic, Rochester, Minn) Gastroenterology 129:113–121, 2005§

Treatment of Advanced Hepatitis C With a Low Accelerating Dosage Regimen of Antiviral TherapyEverson GT, Trotter J, Forman L, et al (Univ of Colorado, Denver) Hepatology 42:255–262, 2005§

High-Dose Ribavirin in Combination With Standard Dose Peginterferon for Treatment of Patients With Chronic Hepatitis CLindahl K, Stahle L, Bruchfeld A, et al (Karolinska Univ, Huddinge, Sweden; Karolinska Inst, Stockholm) Hepatology 41:275–279, 2005§

Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver TransplantationShergill AK, Khalili M, Straley S, et al (Univ of California San Francisco) Am J Transplant 5:118–124, 2005§

Surgically-induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic SyndromeMattar SG, Velcu LM, Rabinovitz M, et al (Univ of Pittsburgh, Pa; Cleveland Clinic Found, Ohio) Ann Surg 242:610–620, 2005§